Ascend Wellness Is No Longer The Cheapest MSO - Seeking Alpha

Nov 5, 2023 · Ascend Wellness has seen a 43% rally in its stock since mid-June due to the potential rescheduling of cannabis and the elimination of the punitive 280E tax. The company …

43%
OFF

Ascend Wellness Is No Longer The Cheapest MSO - Seeking Alpha

1 week from now

Nov 5, 2023 · Ascend Wellness has seen a 43% rally in its stock since mid-June due to the potential rescheduling of cannabis and the elimination of the punitive 280E tax. The company …

seekingalpha.com

$3.05
OFF

I Still Like Ascend Wellness Despite The Management Turnover

1 week from now

Oct 28, 2024 · Ascend Is the Cheapest MSO. ... I no longer expect that the $3.05 level will be hit by year-end, but I remain very optimistic. 6X the lower projected adjusted EBITDA would lead …

seekingalpha.com

$0.05
OFF

Ascend Wellness Holdings GAAP EPS Of -$0.05, Revenue Of …

1 week from now

Ascend Wellness Is No Longer The Cheapest MSO; Ascend Wellness Is Ascending But Still Very Cheap; Ascend Wellness Holdings, Inc. 2023 Q2 - Results - Earnings Call Presentation; …

msn.com

1%
OFF

Ascend Wellness' 20.1% Wholesale Growth, Wider Net Loss In Q3

1 week from now

3 days ago · Ascend Wellness reported Q3 revenue amounted to $141.6 million, up 0.3% year-over-year and 0.1% quarter-over-quarter. Q3 net loss was $28.3 million, compared to a net …

benzinga.com

6%
OFF

Ascend Has Become The Cheapest MSO - Seeking Alpha

1 week from now

Jun 12, 2023 · AAWH posted a new all-time closing low of $0.684 on Thursday, and it rallied to $0.70 on Friday while setting a new all-time intraday low of $0.61. It dropped 13.6% last week …

seekingalpha.com

$140
OFF

Cannabis Acquisitions Pay Off: MSO Ascend Wellness Q4

1 week from now

Mar 12, 2024 · Multi-state cannabis operator Ascend Wellness AAWH AAWH reported its financial results Tuesday for the fourth quarter and full year, revealing quarterly revenue of $140.2 …

benzinga.com

50%
OFF

The Best Big MSOs To Buy (OTCMKTS:CRLBF) - Seeking Alpha

1 week from now

5 days ago · I have more than 50% of my model portfolio at 420 Investor in 6 MSOs currently. Two of these are large ones: Cresco Labs (CRLBF) and Verano Holdings (VRNOF).

seekingalpha.com

FAQs about Ascend Wellness Is No Longer The Cheapest MSO - Seeking Alpha Coupon?

Is ascend Wellness a good MSO?

Ascend Wellness is a strong but cheap Tier 2 MSO. While the 2024 revenue and adjusted EBITDA estimates have been stable since the company reported its Q4 in March, AAWH stock has sunk sharply to a new all-time low. I have boosted exposure in my model portfolios and think the stock can more than double over the balance of the year. ...

Is ascend Wellness a good stock to buy in 2023?

Ascend Wellness has rallied 29.5% in 2023, but this is less than most other MSOs. The stock has big upside potential, though it could fall sharply too if cannabis is not rescheduled. It is the cheapest Tier 1 or Tier 2 MSO again. Looking for a helping hand in the market? ...

Is ascend Wellness a good investment despite a Q2 Miss?

Ascend Wellness (AAWH) shows strong growth despite a Q2 miss. The new management aims for long-term success. Click here for a full investment analysis. ...

Is ascend a good stock to buy?

The stock has dropped the most of the four and almost twice as much as the New Cannabis Ventures Global Cannabis Stock Index, which is down 21.1%. Ascend has a very low valuation at just 3X enterprise value to projected adjusted EBITDA in 2024, the lowest among the top MSOs: ...

How did ascend wellness perform in 2023?

Ascend Wellness grew net revenue by 28% in 2023 to $518.6 million. The gross margin fell from 33.1% to 29.9%. Fortunately, its operating expenses expanded only 12%, aided by the lack of a settlement expense. Removing the $5 million charge from the 2022 results, operating expenses expanded by 16%. ...

Is ascend a good stock to buy in 2025?

Its peers, though, have seen decreases in their adjusted EBITDA estimates and much higher prices. For 2025, Ascend is also the cheapest at just 3.7X. The average is 7.3X, If cannabis is rescheduled to Schedule 3, then the 280E tax will be eliminated. This would be a very good thing for the MSOs, and it could allow valuations to expand. ...